Parker‑Hannifin (PH) Insider Award: 4,444 Stock Appreciation Rights
Rhea-AI Filing Summary
Bendali Rachid, Vice President & President, Engineering Material Group at Parker-Hannifin Corporation (PH), reported acquiring 4,444 stock appreciation rights (SARs) on 08/20/2025 under a Form 4 filing. The SARs show a listed exercise/conversion price of $742.97 and are reported as acquired (Code A). The award is direct and converts into 4,444 shares of common stock if exercised.
The filing notes the SAR award vests in three equal annual installments beginning 08/20/2026, and the SARs have an exercisable/expiration window shown from 08/20/2026 to 08/19/2035. The Form 4 was signed by an attorney-in-fact on 08/22/2025.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider received a time‑based SAR award of 4,444 units with multi-year vesting and a $742.97 exercise price.
The Form 4 documents a routine equity‑linked compensation grant to a senior executive rather than an open‑market purchase or sale. The award vests in three equal annual installments starting 08/20/2026 and covers 4,444 underlying common shares, exercisable through 08/19/2035. For investors, this is a standard long‑dated incentive vehicle that ties compensation to future share performance; the filing itself is not a material corporate event but is relevant for understanding insider compensation trends.
TL;DR: This disclosure records a standard executive SAR grant with staged vesting and a long exercise window.
The disclosure provides clear terms: acquisition date 08/20/2025, vesting in three equal annual installments beginning 08/20/2026, and an exercisable/expiration range through 08/19/2035. The Form 4 was filed promptly and signed by an authorized attorney‑in‑fact. As a governance item, it documents compliance with Section 16 reporting requirements; there is no indication of accelerated vesting, amendments, or related-party transactions in the filing.
FAQ
What insider transaction did Parker-Hannifin (PH) report on the Form 4?
What is the exercise or conversion price for the SARs reported on the Form 4?
When do the SARs begin vesting and over what schedule?
How many shares underlie the reported derivative award and what is the ownership form?
What are the exercisable and expiration dates listed for the SARs?